Literature DB >> 31853241

Barriers of Mucosal Entry of HIV/SIV.

Ann M Carias1, Thomas J Hope1.   

Abstract

Most new HIV infections, over 80%, occur through sexual transmission. During sexual transmission, the virus must bypass specific female and male reproductive tract anatomical barriers to encounter viable target cells. Understanding the generally efficient ability of these barrier to exclude HIV and the precise mechanisms of HIV translocation beyond these genital barriers is essential for vaccine and novel therapeutic development. In this review, we explore the mucosal, barriers of cervico-vaginal and penile tissues that comprise the female and male reproductive tracts. The unique cellular assemblies f the squamous and columnar epithelium are illustrate highlighting their structure and function. Each anatomical tissue offers a unique barrier to virus entry in healthy individuals. Unfortunately barrier dysfunction can lead to HIV transmission. How these diverse mucosal barriers have the potential to fail is considered, highlighting those anatomical areas that are postulated to offer a weaker barrier and are; therefore, more susceptible to viral ingress. Risk factors, such as sexually transmitted infections, microbiome dysbiosis, and high progestin environments are also associated with increased acquisition of HIV. How these states may affect the integrity of mucosal barriers leading to HIV acquisition are discussed suggesting mechanisms of transmission and revealing potential targets for intervention.

Entities:  

Keywords:  HIV infection; HIV risk; female reproductive tract; hormonal contraception; target cells; vaginal transmission

Year:  2019        PMID: 31853241      PMCID: PMC6919325          DOI: 10.2174/1573395514666180604084404

Source DB:  PubMed          Journal:  Curr Immunol Rev        ISSN: 1573-3955


  95 in total

1.  The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations.

Authors:  H A Weiss; A Buvé; N J Robinson; E Van Dyck; M Kahindo; S Anagonou; R Musonda; L Zekeng; L Morison; M Caraël; M Laga; R J Hayes
Journal:  AIDS       Date:  2001-08       Impact factor: 4.177

2.  Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone.

Authors:  Jeffrey Pudney; Alison J Quayle; Deborah J Anderson
Journal:  Biol Reprod       Date:  2005-08-10       Impact factor: 4.285

3.  Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.

Authors:  Maria J Wawer; Ronald H Gray; Nelson K Sewankambo; David Serwadda; Xianbin Li; Oliver Laeyendecker; Noah Kiwanuka; Godfrey Kigozi; Mohammed Kiddugavu; Thomas Lutalo; Fred Nalugoda; Fred Wabwire-Mangen; Mary P Meehan; Thomas C Quinn
Journal:  J Infect Dis       Date:  2005-03-30       Impact factor: 5.226

4.  Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study.

Authors:  J M Baeten; P M Nyange; B A Richardson; L Lavreys; B Chohan; H L Martin; K Mandaliya; J O Ndinya-Achola; J J Bwayo; J K Kreiss
Journal:  Am J Obstet Gynecol       Date:  2001-08       Impact factor: 8.661

Review 5.  HIV/AIDS in women: an expanding epidemic.

Authors:  Thomas C Quinn; Julie Overbaugh
Journal:  Science       Date:  2005-06-10       Impact factor: 47.728

6.  Progesterone implants enhance SIV vaginal transmission and early virus load.

Authors:  P A Marx; A I Spira; A Gettie; P J Dailey; R S Veazey; A A Lackner; C J Mahoney; C J Miller; L E Claypool; D D Ho; N J Alexander
Journal:  Nat Med       Date:  1996-10       Impact factor: 53.440

Review 7.  Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis.

Authors:  Kimberly A Powers; Charles Poole; Audrey E Pettifor; Myron S Cohen
Journal:  Lancet Infect Dis       Date:  2008-08-04       Impact factor: 25.071

8.  Depot medroxyprogesterone acetate increases immune cell numbers and activation markers in human vaginal mucosal tissues.

Authors:  Neelima Chandra; Andrea Ries Thurman; Sharon Anderson; Tina Duong Cunningham; Nazita Yousefieh; Christine Mauck; Gustavo F Doncel
Journal:  AIDS Res Hum Retroviruses       Date:  2012-11-28       Impact factor: 2.205

9.  Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1.

Authors:  Florian Hladik; Polachai Sakchalathorn; Lamar Ballweber; Gretchen Lentz; Michael Fialkow; David Eschenbach; M Juliana McElrath
Journal:  Immunity       Date:  2007-02       Impact factor: 31.745

10.  Human cervicovaginal mucus contains an activity that hinders HIV-1 movement.

Authors:  S A Shukair; S A Allen; G C Cianci; D J Stieh; M R Anderson; S M Baig; C J Gioia; E J Spongberg; S M Kauffman; M D McRaven; H Y Lakougna; C Hammond; P F Kiser; T J Hope
Journal:  Mucosal Immunol       Date:  2012-09-19       Impact factor: 7.313

View more
  6 in total

Review 1.  The Penis, the Vagina and HIV Risk: Key Differences (Aside from the Obvious).

Authors:  Rupert Kaul; Cindy M Liu; Daniel E Park; Ronald M Galiwango; Aaron A R Tobian; Jessica L Prodger
Journal:  Viruses       Date:  2022-05-27       Impact factor: 5.818

Review 2.  The Microbiome as a Key Regulator of Female Genital Tract Barrier Function.

Authors:  Andrew Plesniarski; Abu Bakar Siddik; Ruey-Chyi Su
Journal:  Front Cell Infect Microbiol       Date:  2021-12-17       Impact factor: 5.293

Review 3.  HIV Infection and Spread between Th17 Cells.

Authors:  Janet P Zayas; João I Mamede
Journal:  Viruses       Date:  2022-02-16       Impact factor: 5.048

Review 4.  The Effect of Gender-Affirming Medical Care on the Vaginal and Neovaginal Microbiomes of Transgender and Gender-Diverse People.

Authors:  Yonah Krakowsky; Emery Potter; Jason Hallarn; Bern Monari; Hannah Wilcox; Greta Bauer; Jacques Ravel; Jessica L Prodger
Journal:  Front Cell Infect Microbiol       Date:  2022-01-21       Impact factor: 5.293

5.  Lactic acid from vaginal microbiota enhances cervicovaginal epithelial barrier integrity by promoting tight junction protein expression.

Authors:  David Jose Delgado-Diaz; Brianna Jesaveluk; Joshua A Hayward; David Tyssen; Arghavan Alisoltani; Matthys Potgieter; Liam Bell; Elizabeth Ross; Arash Iranzadeh; Imane Allali; Smritee Dabee; Shaun Barnabas; Hoyam Gamieldien; Jonathan M Blackburn; Nicola Mulder; Steven B Smith; Vonetta L Edwards; Adam D Burgener; Linda-Gail Bekker; Jacques Ravel; Jo-Ann S Passmore; Lindi Masson; Anna C Hearps; Gilda Tachedjian
Journal:  Microbiome       Date:  2022-08-31       Impact factor: 16.837

6.  Complement-Opsonized HIV Modulates Pathways Involved in Infection of Cervical Mucosal Tissues: A Transcriptomic and Proteomic Study.

Authors:  Cecilia Svanberg; Rada Ellegård; Elisa Crisci; Mohammad Khalid; Ninnie Borendal Wodlin; Maria Svenvik; Sofia Nyström; Kenzie Birse; Adam Burgener; Esaki M Shankar; Marie Larsson
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.